Epidural Stimulation for Spinal Cord Injury
Trial Summary
What is the purpose of this trial?
The investigators propose to determine the electrode configurations that promote functional gains in the storage and voiding phases of lower urinary tract function as a result of activation of spinal circuits with spinal cord epidural stimulation in humans with spinal cord injury. The innovative approach and novel application of the Medtronic Specify 5-6-5 (16-electrode array) epidural device will allow the investigators to determine, with this early feasibility study, specific parameters of spinal cord epidural stimulation and approaches for bladder training needed for lower urinary tract function which will lay the groundwork for expedient translation of this promising technology to larger numbers of individuals with spinal cord injury who currently have limited treatment options. The current proposed study will increase the understanding of human lumbosacral spinal networks and guide the use of innovative therapeutic strategies that would be immediately available to not only improve the motor output during standing and walking but also ameliorate bladder dysfunction and thus improve quality of life in individuals after spinal cord injury.
Do I need to stop my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Epidural Stimulation for Spinal Cord Injury?
Research shows that epidural electrical stimulation (EES) can help people with spinal cord injuries regain some control over their muscles, allowing them to stand and make stepping movements. In one case, a person with paraplegia was able to perform these tasks within just two weeks of starting EES therapy.12345
Is epidural stimulation generally safe for humans?
How is the treatment Epidural Stimulation unique for spinal cord injury?
Epidural Stimulation is unique because it involves applying electrical currents directly to the spinal cord, which can help restore movement and control in people with spinal cord injuries. Unlike other treatments, it can enable voluntary control of muscles and improve standing and stepping abilities, even in cases of severe paralysis.145710
Research Team
Susan Harkema, PhD
Principal Investigator
University of Louisville
Eligibility Criteria
This trial is for individuals with stable spinal cord injuries (SCI) who are at least two years post-injury, have an implanted epidural stimulator, and show signs of recovery from spinal shock. It's not suitable for those with certain medical conditions, ongoing drug abuse, recent bladder treatments like Botox injections or surgeries that change the way urine leaves the body.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive spinal cord epidural stimulation to enhance bladder storage and voiding phases
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Epidural Stimulation
Epidural Stimulation is already approved in United States, Canada, European Union for the following indications:
- Spinal cord injury rehabilitation
- Motor function recovery
- Autonomic function recovery
- Spinal cord injury rehabilitation
- Motor function recovery
- Autonomic function recovery
- Spinal cord injury rehabilitation
- Motor function recovery
- Autonomic function recovery
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Louisville
Lead Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
National Institutes of Health (NIH)
Collaborator